The abstract is read at the publisher; the summary is JClub's.
In 343 sickle cell disease patients, plasma proteomics of 5,411 proteins identified 560 protein quantitative trait loci, including 58 novel pQTL linked to genetic variation.
- Why it matters: Therapeutic options for sickle cell disease are limited, and human genetics plus proteomics can reveal drug targets by connecting DNA variation to circulating protein levels.
- What they did: The study measured 5,411 plasma proteins and tested associations with common genetic variation in 343 patients, then used conditional analyses to call 560 pQTL and assess overlap with non-SCD African Americans in the Million Veteran Program.
- The result: Most pQTL effect sizes were concordant across SCD and non-SCD groups, while examples like APOL1 and haptoglobin showed heterogeneity; Mendelian randomization prioritized four proteins—ENPP5, LBP, PTX3, ZP3—that may increase fetal hemoglobin production.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.